Adynovate

Takeda's Baxalta settles with Bayer over $173M hemophilia patent infringement verdict
Fierce Pharma
Wed, 05/19/21 - 11:05 pm
Baxalta
Takeda
hemophilia
patents
Bayer
Adynovate
Nektar sells off royalties on its 2 approved drugs for $150M in cash, redoubling focus on I-O candidates
Endpoints
Wed, 12/23/20 - 10:44 am
Nektar Therapeutics
Adynovate
Movantik
HealthCare Royalty Partners
Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement
BioSpace
Wed, 02/6/19 - 11:17 am
Takeda
clinical trials
Adynovate
Baxalta
Bayer
patents
Shire's latest approval won't save it from Hemlibra
Biopharma Dive
Wed, 01/17/18 - 09:58 pm
Shire
Hemlibra
Adynovi
hemophilia
Europe
Adynovate
FDA approves Baxalta's drug for rare bleeding disorder
Yahoo/Reuters
Fri, 11/13/15 - 08:45 pm
Baxalta
FDA
Adynovate